Skip to main content
Caplight Logo









Anthrogen

Anthrogen

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.anthrogen.com/

Last Round

Seed

Nov 12, 2024

Total Funding Raised

$4.5M

Company Overview

Anthrogen is a bioengineering company that operates a platform to generate molecular machines for applications in human health, carbon capture, and industrial manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, ML Platforms, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Foundation

Keywords

protein language modeldrug discoveryprotein engineeringfoundation modelgenerative biologyfrontier ai labbiotech aidiscrete diffusionprotein designcomputational biologyin silico drug discoveryai for scienceapi platformtherapeutic developmentusage-based billing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anthrogen Comparables

Compare Anthrogen with similar companies based on industry and business-model similarity.

Anthrogen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EvolutionaryScale
92%
310.ai
89%
OpenProtein.AI
85%

Anthrogen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 12, 2024
Pre SeedJun 7, 2024

Anthrogen Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 23, 2025

    Launched Odyssey, a 102B parameter model using Consensus and discrete diffusion.

  • Nov 12, 2024

    $4M raised in Seed round.

Anthrogen Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Anthrogen Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Anthrogen's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range9
Year Founded2024
Last FundingNov 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?